Compare Pfizer Inc (PFE) vs Vivmark Residential Common Shares of Beneficial Interest (VMRK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Vivmark Residential Common Shares of Beneficial Interest — how do they compare? Pfizer Inc trades at $27.78 (market cap $159.59B), while Vivmark Residential Common Shares of Beneficial Interest trades at $60.01 (market cap $45.88B). The key difference: Pfizer Inc is far larger — about 3.5× Vivmark Residential Common Shares of Beneficial Interest's market cap, and Pfizer Inc pays the higher dividend (6.14%). Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and Vivmark Residential Common Shares of Beneficial Interest for 0 Days on average.
| PFE | VMRK | |
|---|---|---|
Market Cap | $159.59B | $45.88B |
Volume | 30,937,010 | 4,028,975 |
Sector | Health | Real Estate |
52-Week High | $29.02 | $70.15 |
52-Week Low | $23.67 | $57.98 |
Typical Hold Time | 158 Days | 0 Days |
Enterprise Value | $211.09B | $54.98B |
Dividend Yield | 6.14% | 4.74% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $27.82, up 1.22% with a bullish technical signal from moving averages. The company shows stable revenue around $62-63B with consistent earnings beats in recent quarters. Analysts maintain a $29.40 consensus target with 40% buy ratings. Recent news highlights Pfizer's focus on obesity and oncology pipelines as key growth drivers.
Pfizer offers value with defensive cash flows and dividend stability, though patent cliffs and margin compression present challenges. The stock's current valuation appears reasonable relative to sector peers, with upside potential if pipeline developments succeed. Key risks include competitive pressures and regulatory hurdles for new drug approvals.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Vivmark Residential Common Shares of Beneficial Interest
Vivmark Residential is a residential real estate investment trust that owns and operates apartment communities in U.S. markets. Its portfolio includes apartment homes and development projects.
Read more on VMRK →
